2201 Murphy Ave., Suite 212 Nashville, TN 37203
Tel: 615-320-6076
Fax: 615-320-6068
The Allevia 2 clinical trial will help us learn if an investigational medicine can control symptoms in people with Tourette Syndrome. This medicine has not yet been approved for the treatment of Tourette Syndrome and is being investigated in clinical trials.
What to expect from the Allevia 2 clinical trial
How long will I be in this clinical trial?
-
About 5 months
How often will I visit the trial site?
-
About 7 visits to the trial site
-
1 remote visit by telephone or computer
What will happen at the trial visits?
-
Most trial visits will take about 2-3 hours. When you visit the site, you will havve blood and urine tests, and be asked to complete questionnaires about your Tourette Syndomre symptoms and general health.​
Noema Allevia 2 Study
What will happen during the trial?
Participants in this trial will receive either the study treatment or a placebo. This is to test whether any possible effects of the treatment are to gemlapodect. The study treatment wil be provided as capsules to be taken orally each morning. At the beginning of the treatment, the dose will be graduallyincreased towards a maximum level to see what doses may or may not work.